Michelle Robertson
CIK 1755098 · EVP, CHIEF FINANCIAL OFFICER · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EDIT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
919 EAST HILLSDALE BOULEVARD, SUITE 250
FOSTER CITY, CA 94404
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VSTM | Director | 52,666 | $8.78 | $462.4K | $0 | 8 | 2026-05-26 |
| GERN | EVP, CHIEF FINANCIAL OFFICER | 17,645 | $1.23 | $21.7K | -$19.1K | 5 | 2026-02-19 |
| EDIT | EVP, CHIEF FINANCIAL OFFICER | 106,610 | $2.48 | $263.9K | -$545.0K | 16 | 2023-05-15 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Chief Financial Officer | 6,813 | — | — | -$169.8K | 7 | 2019-10-29 |
Recent Filings · Page 2 of 4
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-15 | EDIT | Sell (S) | −949 | -$9.4K | EDGAR |
| 2023-05-11 | EDIT | Notice (144) | −3,000 | -$10.8K | EDGAR |
| 2023-03-06 | EDIT | Mixed | +31,316 | -$1.6K | EDGAR |
| 2023-02-15 | EDIT | Sell (S) | −4,287 | -$41.4K | EDGAR |
| 2023-01-12 | EDIT | Sell (S) | −1,752 | -$14.3K | EDGAR |
| 2022-12-20 | VSTM | Grant (A) | — | $0 | EDGAR |
| 2022-12-06 | EDIT | Sell (S) | −193 | -$2.0K | EDGAR |
| 2022-09-08 | EDIT | Sell (S) | −192 | -$2.9K | EDGAR |
| 2022-06-24 | VSTM | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | EDIT | Sell (S) | −1,527 | -$17.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.